Syngene International Limited
SYNGENE

Syngene International Limited

Healthcare Research, Analytics & Technology
Share price
₹452
Market cap
₹18,240 Cr
1Y return
▼ 29%

India's first Contract Research Organization, Syngene provides integrated drug discovery, development, and manufacturing services through a single platform known as CRAMS. Established in 1993 as a Biocon subsidiary, the company operates extensive research and manufacturing facilities spanning multiple locations across the country. It serves global pharmaceutical and biotechnology clients with end-to-end solutions, from early-stage research through commercial-scale production.

Investors holding Syngene International Limited

8.00%
DSP Mutual Fund
DSP Mutual Fund
Mutual Fund
4.71%
SBI Mutual Fund
SBI Mutual Fund
Mutual Fund
3.10%
LIC
LIC
Institution
1.78%
Government of Singapore
Government of Singapore
Foreign Investor
1.16%
1.05%
Tata Mutual Fund
Tata Mutual Fund
Mutual Fund
1.02%

Recent moves 21

Moves21
HSBC Mutual FundExited
HSBC Mutual Fund is no longer listed among the key shareholders of Syngene International Limited, having previously held 1.55 percent. This change indicates that HSBC Mutual Fund either completely exited the position or trimmed it below the 1 percent reporting threshold.
16 Oct 2026
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund decreased its stake in Syngene International Limited from 1.85% to 1.05%, selling 31,95,263 shares.
16 Oct 2026
Read more
Tata Mutual FundNew position
Tata Mutual Fund acquired a 1.02% stake in Syngene International Limited, holding 41,09,003 shares. Its holding rose to 1.02% from under 1% in the latest shareholding update.
16 Oct 2026
Read more
DSP Mutual FundIncreased
DSP Mutual Fund increased its stake in Syngene International Limited from 4.61% to 4.71% by acquiring 4,26,177 shares, taking its total holding to 1,90,18,962 shares.
16 Oct 2026
Read more
Nippon India Mutual FundIncreased
Nippon India Mutual Fund increased its stake in Syngene International Limited from 7.73% to 8.00%. The fund house acquired 11,09,508 shares, raising its total holding to 3,22,95,397 shares.
16 Oct 2026
Read more
Government of SingaporeDecreased
The Government of Singapore reduced its stake in Syngene International from 2.13% to 1.16%, selling 39.3 lakh shares.
16 Oct 2026
Read more
SBI Mutual FundIncreased
SBI Mutual Fund raised its stake in Syngene International from 1.95% to 3.10% by purchasing 46,50,502 shares.
16 Oct 2026
Read more
ICICI Prudential Mutual FundIncreased
ICICI Prudential Mutual Fund raised its stake in Syngene International Limited from 5.30% to 6.82%. The fund acquired 61,44,880 shares, increasing its total holding to 2,75,28,631 shares.
16 Oct 2026
Read more
Mirae Asset Mutual FundDecreased
Mirae Asset Mutual Fund trimmed its Syngene International stake from 1.02% to 0.81%, selling 8,61,450 shares via open market sale.
21 Jul 2026
Read more
UTI Mutual FundExited
UTI Mutual Fund, which previously held 1.16 percent of Syngene International Limited, is no longer listed among its disclosed shareholders, indicating either a complete sale or a reduction in stake below the 1 percent reporting threshold.
19 Jul 2026
Read more

Track the whales in Syngene International Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1